MarginsXMarginsX
Home › Markets › APTN

Adaptin Bio, Inc. (APTN)

APTN is quoted over the counter, not listed on an exchange. Adaptin Bio, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close
No daily closes stored yet
No new price since Aug 19, 2026: the price source has sent no bar for 62 sessions
1-year return
No daily closes stored yet
Market cap
$58.1M
Micro cap. From the Aug 19, 2026 close × 9.3M shares (10-Q cover page, Nov 12, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to June 30, 2026 (10-Q)

Profile

FieldValue
TickerAPTN, quoted over the counter
SEC CIK0001938571
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeBiological Products, (No Diagnostic Substances)
Business addressCharlotte, NC
Incorporated inDE

Warning signs

Cash runway
3.2 months
$670K cash at June 30, 2026
Share count, 1 year
+9.5%
2025-11-13 to 2026-11-12 · +85.2% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These matters raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-13
Cash and burn$670K cash; operating cash flow -$630K a quarter.Report 2026-06-30
Shares outstanding9,261,601 (2026-11-12); 8,455,829 a year earlier; 5,000,000 three years earlier.Cover page 2026-11-12
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWithumSmith+Brown, PC, East Brunswick, New Jersey, United States; changed auditors 1 time in 24 months8-K 4.01 2025-02-18
Late filings, 12 months1 NT noticeNT 10-K 2026-04-01
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$1.2M-$450K$670KNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$1.1M-$596K$301KNo debt tagsNeeds four quarters10-Q 2026-08-13
Q4 2025
2025-12-31
Not filed-$1.4M-$703K$459KNo debt tagsNeeds four quarters10-K 2026-04-01
Q3 2025
2025-09-30
Not filed-$1.7M-$772K$579KNo debt tagsNeeds four quarters10-Q 2025-11-14
Q2 2025
2025-06-30
Not filed-$1.5M-$1.0M$1.4MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$603K-$2.3M$2.4MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q4 2024
2024-12-31
Not filed-$857K$113K$34K$1.5MNeeds four quarters10-K 2026-04-01
Q3 2024
2024-09-30
Not filed-$1.1M-$468K$115K$138KNeeds four quarters10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-09-10
Latest annual report10-K/A2026-06-12
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-08-25

Source: SEC EDGAR submissions feed, 76 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier